Model-informed drug repurposing of proton pump inhibitors for the prevention of oxaliplatin induced peripheral neuropathy: A real-world data analysis and pharmacometrics approach.
- DOI
- 10.1007/s00280-025-04801-9
- Published
- 2025 Aug 7
- Container
- Cancer chemotherapy and pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00280-025-04801-9,
title = {Model-informed drug repurposing of proton pump inhibitors for the prevention of oxaliplatin induced peripheral neuropathy: A real-world data analysis and pharmacometrics approach.},
author = {Tsukushi Y and Koriyama K and Kobuchi S and Matsumoto K and Ito Y and Sakaeda T},
year = {2025},
journal = {Cancer chemotherapy and pharmacology},
doi = {10.1007/s00280-025-04801-9},
url = {https://doi.org/10.1007/s00280-025-04801-9}
}RIS
TY - JOUR TI - Model-informed drug repurposing of proton pump inhibitors for the prevention of oxaliplatin induced peripheral neuropathy: A real-world data analysis and pharmacometrics approach. AU - Tsukushi Y AU - Koriyama K AU - Kobuchi S AU - Matsumoto K AU - Ito Y AU - Sakaeda T PY - 2025 JO - Cancer chemotherapy and pharmacology DO - 10.1007/s00280-025-04801-9 UR - https://doi.org/10.1007/s00280-025-04801-9 ER -
APA
Y, T., K, K., S, K., K, M., Y, I., & T, S. (2025). Model-informed drug repurposing of proton pump inhibitors for the prevention of oxaliplatin induced peripheral neuropathy: A real-world data analysis and pharmacometrics approach.. Cancer chemotherapy and pharmacology. https://doi.org/10.1007/s00280-025-04801-9
Source records
- pubmed · retrieved 2026-09-27T00:33:29.465Z